ABSK-011
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ABSK-011, covering 2025-12-10 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor [Phase 1]